Darvadstrocel
Medicine / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Darvadstrocel?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Darvadstrocel, sold under the brand name Alofisel, is a medication used to treat complex perianal fistulas in adults with non-active/mildly active luminal Crohn's disease when fistulas have shown an inadequate response to at least one conventional or biologic therapy.[1] It contains mesenchymal stem cells from fat tissue of adult donors.[2]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Alofisel |
Other names | CX-601 |
Routes of administration | Injection |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
DrugBank | |
UNII | |
KEGG |
Close
It was approved for use in the European Union in March 2018.[2] The approval was spearheaded by data published in the ADMIRE-CD trial.[2][3]
It was approved for use in Japan by Japan's Ministry of Health, Labour and Welfare (MHLW) in September 2021.[4]